Viridian appoints Jeff Ajer to board; grants stock options to 14 new employees

Viridian Therapeutics, Inc.\DE

Jeff Ajer, former BioMarin CCO with 25+ years rare disease experience, appointed to VRDN board effective April 7, 2025.
Ajer led launches of 5 brands at BioMarin; will support veligrotug BLA submission and potential commercial launch.
Compensation Committee approved inducement grants of options for 220,750 shares to 14 new employees on April 1, 2025.
Options vest over 4 years (25% at one-year anniversary, then monthly), exercise price equals closing price on grant date.
Appointment strengthens board as Viridian advances veligrotug and FcRn portfolio toward regulatory milestones.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeff Ajer

Director

VRDN · Viridian Therapeutics, Inc.\DE

Effective: 2025-04-07
Filed: April 7, 2025, 7:59 PM ET

On April 2, 2025, the Board of Directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”), appointed Jeff Ajer to serve as a Class I director of the Company, effective as of April 7, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeff Ajer was appointed as Director at Viridian Therapeutics, Inc.\DE.

Action: appointed
Role: Director

Exact text from the filing

On April 2, 2025, the Board of Directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”), appointed Jeff Ajer to serve as a Class I director of the Company, effective as of April 7, 2025.

View on SEC.gov

Viridian Therapeutics, Inc.\DE filing history →

Source: SEC EDGAR

accession 0001193125-25-073937

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.